Prevalence of VZV Reactivation and Effectiveness of Vaccination with Recombinant Adjuvanted Zoster Vaccine in Allogeneic Hematopoietic Stem Cell Recipients—A Single-Center Analysis

Prevalence of VZV Reactivation and Effectiveness of Vaccination with Recombinant Adjuvanted Zoster Vaccine in Allogeneic Hematopoietic Stem Cell Recipients—A Single-Center Analysis

Background: Secondary immunodeficiencies in allo-HSCT (allogeneic hematopoietic stem cell transplantation) recipients increase the risk of viral reactivation, making vaccinations a vital issue. There is a paucity of data on the use of recombinant vaccine against herpes zoster (RZV) after allo-HSCT....

Full description

Saved in:
Bibliographic Details
Main Authors: Ewa Karakulska-Prystupiuk, Magdalena Feliksbrot-Bratosiewicz, Maria Król, Agnieszka Tomaszewska, Wiesław Wiktor Jędrzejczak, Grzegorz Władysław Basak
Format: Article
Language:English
Published: MDPI AG 2025-05-01
Series:Infectious Disease Reports
Subjects:
recombinant adjuvanted herpes zoster vaccine (RZV)
herpes zoster (HZ)
allogeneic hematopoietic stem cell transplantation (allo-HSCT)
secondary immunodeficiency (SID)
Online Access:https://www.mdpi.com/2036-7449/17/3/48
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/2036-7449/17/3/48

Similar Items